Natural bone collagen scaffold combined with autologous enriched bone marrow cells for induction of osteogenesis in an ovine spinal fusion model

Tissue Engineering - Part A

Volumn 15, Issue 11, 2009, Pages 3547-3558

  Qian, Yu ^a,b   Lin, Zhen ^a,c   Chen, Jimin ^a   Fan, Ying ^d   Davey, Tamara ^a   Cake, Martin ^e   Day, Robert ^a   Dai, Kerong ^f   Xu, Jiake ^a   Zheng, Minghao ^a,g  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SHAOXING PEOPLE S HOSPITAL   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Perth Bone and Tissue Bank Inc   (Australia)

^e MURDOCH UNIVERSITY   (Australia)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^g SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CELLS; COLLAGEN; GRAFTING (CHEMICAL); SCAFFOLDS;

BONE FORMATION; BONE GRAFT; BONE GRAFTING; BONE MARROW CELLS; BONE TISSUE; BONE VOLUME; CELL SOURCES; COLLAGEN TYPE I; FUSION SITES; IN-VITRO; IN-VIVO; INTERBODY FUSION MODEL; LUMBAR DISC; MATRIX; NATURAL BONE; OSTEOGENESIS; POPULATION EXPANSION; SPINAL FUSION;

BONE;

COLLAGEN TYPE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BIOMECHANICS; BONE DEVELOPMENT; BONE GRAFT; CELL CULTURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; SPINE FUSION; TISSUE ENGINEERING;

OVIS;

EID: 72649102634     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0076     Document Type: Article

References (72)

1. Skaggs, D.L., Samuelson, M.A., Hale, J.M., Kay, R.M., Tolo, V.T. Complications of posterior iliac crest bone grafting in spine surgery in children. Spine 25, 2400, 2000.
2. Seiler, J.G. 3rd, Johnson, J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 9, 91, 2000.
3. Goulet, J.A., Senunas, L.E., DeSilva, G.L., Greenfield, M.L. Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res 76, 1997.
4. Arrington, E.D., Smith, W.J., Chambers, H.G., Bucknell, A.L., Davino, N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 300, 1996.
5. Kuhn, D.A., Moreland, M.S. Complications following iliac crest bone grafting. Clin Orthop Relat Res 224, 1986.
6. Banwart, J.C., Asher, M.A., Hassanein, R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 20, 1055, 1995.
7. Boden, S.D. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27, S26, 2002.
8. Carlisle, E., Fischgrund, J.S. Bone morphogenetic proteins for spinal fusion. Spine J 5, 240 S, 2005.
9. Handoll, H.H., Watts, A.C. Bone grafts and bone substitutes for treating distal radial fractures in adults. Cochrane Database Syst Rev CD006836, 2008.
10. Gupta, M.C., Theerajunyaporn, T., Maitra, S., Schmidt, M.B., Holy, C.E., Kadiyala, S., Bruder, S.P. Efficacy of mesenchy-mal stem cell enriched grafts in an ovine posterolateral lumbar spine model. Spine 32, 720, 2007.
11. Morone, M.A., Boden, S.D. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 23, 159, 1998.
12. Minamide, A., Yoshida, M., Kawakami, M., Yamasaki, S., Kojima, H., Hashizume, H., Boden, S.D. The use of cultured bone marrow cells in type I collagen gel and porous hy-droxyapatite for posterolateral lumbar spine fusion. Spine 30, 1134, 2005.
13. Kruyt, M.C., Wilson, C.E., de Bruijn, J.D., van Blitterswijk, C.A., Oner, C.F., Verbout, A.J., Dhert, W.J. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 27, 5099, 2006.
14. Gan, Y., Dai, K., Zhang, P., Tang, T., Zhu, Z., Lu, J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials 29, 3973, 2008.
15. Cornell, C.N., Lane, J.M. Current understanding of osteo-conduction in bone regeneration. Clin Orthop Relat Res S267, 1998.
16. Dawson, J.I., Oreffo, R.O. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys 473, 124, 2008.
17. Paramore, C.G., Lauryssen, C., Rauzzino, M.J., Wadlington, V.R., Palmer, C.A., Brix, A., Cartner, S.C., Hadley, M.N. The safety of OP-1 for lumbar fusion with decompression-a canine study. Neurosurgery 44, 1151, 1999.
18. Jorgensen, C., Djouad, F., Bouffi, C., Mrugala, D., Noel, D. Multipotent mesenchymal stromal cells in articular diseases. Best Pract Res Clin Rheumatol 22, 269, 2008.
19. Friedenstein, A.J., Gorskaja, J.F., Kulagina, N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4, 267, 1976.
20. Muraglia, A., Cancedda, R., Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7), 1161, 2000.
21. Colter, D.C., Sekiya, I., Prockop, D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98, 7841, 2001.
22. Pochampally, R.R., Smith, J.R., Ylostalo, J., Prockop, D.J. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103, 1647, 2004.
23. Koga, A., Tokuhashi, Y., Ohkawa, A., Nishimura, T., Ta-kayama, K., Ryu, J. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolat-eral spinal fusion in rabbits. Spine 33, 1318, 2008.
24. Miyazaki, M., Zuk, P.A., Zou, J., Yoon, S.H., Wei, F., Mor-ishita, Y., Sintuu, C., Wang, J.C. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine 33, 863, 2008.
25. Yao, G., Qian, Y., Chen, J., Fan, Y., Stoffel, K., Yao, F., Xu, J., Zheng, M.H. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertran-sverse process lumbar fusion in a rabbit model. Spine 33, 1935, 2008.
26. Qian, Y., Yao, G., Lin, Z., Chen, J., Fan, Y., Davey, T., Xu, J., Zheng, M.H. Natural bone collagen scaffold combined with OP-1 for bone formation induction in vivo. J Biomed Mater Res B Appl Biomater 2009 Mar 12. [Epub ahead of print].
27. Muschler, G.F., Boehm, C., Easley, K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 79, 1699, 1997.
28. Chen, J., Wang, C., Lu, S., Wu, J., Guo, X., Duan, C., Dong, L., Song, Y., Zhang, J., Jing, D., Wu, L., Ding, J., Li, D. In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res 319, 429, 2005.
29. Blattert, T.R., Delling, G., Dalal, P.S., Toth, C.A., Balling, H., Weckbach, A. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine. Spine 27, 2697, 2002.
30. Becker, S., Maissen, O., Ponomarev, I., Stoll, T., Rahn, B., Wilke, I. Osteopromotion by a beta-tricalcium phosphate/ bone marrow hybrid implant for use in spine surgery. Spine 31, 11, 2006.
31. Blattert, T.R., Delling, G., Weckbach, A. Evaluation of an in-jectable calcium phosphate cement as an autograft substitute for transpedicular lumbar interbody fusion: a controlled, prospective study in the sheep model. Eur Spine J 12, 216, 2003.
32. Li, H., Zou, X., Xue, Q., Egund, N., Lind, M., Bunger, C. Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs. Eur Spine J 13, 354, 2004.
33. Li, H., Zou, X., Xue, Q., Egund, N., Lind, M., Bunger, C. Effects of autogenous bone graft impaction and tricalcium phosphate on anterior interbody fusion in the porcine lumbar spine. Acta Orthop Scand 75, 456, 2004.
34. Li, H., Zou, X., Laursen, M., Egund, N., Lind, M., Bunger, C. The influence of intervertebral disc tissue on anterior spinal interbody fusion: an experimental study on pigs. Eur Spine J 11, 476, 2002.
35. Sandhu, H.S., Toth, J.M., Diwan, A.D., Seim, H.B. 3rd, Kanim, L.E., Kabo, J.M., Turner, A.S. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine 27, 567, 2002.
36. Cottrell, J.M., van der Meulen, M.C., Lane, J.M., Myers, E.R. Assessing the stiffness of spinal fusion in animal models. Hss J 2, 12, 2006.
37. Erulkar, J.S., Grauer, J.N., Patel, T.C., Panjabi, M.M. Flexibility analysis of posterolateral fusions in a New Zealand white rabbit model. Spine 26, 1125, 2001.
38. Meijer, G.J., de Bruijn, J.D., Koole, R., van Blitterswijk, C.A. Cell-based bone tissue engineering. PLoS Med 4, e9, 2007.
39. Okamoto, M., Dohi, Y., Ohgushi, H., Shimaoka, H., Ikeuchi, M., Matsushima, A., Yonemasu, K., Hosoi, H. Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 17, 327, 2006.
40. Li, J.P., Habibovic, P., van den Doel, M., Wilson, C.E., de Wijn, J.R., van Blitterswijk, C.A., de Groot, K. Bone ingrowth in porous titanium implants produced by 3D fiber deposition. Biomaterials 28, 2810, 2007.
41. Kruyt, M.C., Dhert, W.J., Oner, C., van Blitterswijk, C.A., Verbout, A.J., de Bruijn, J.D. Optimization of bone-tissue engineering in goats. J Biomed Mater Res B Appl Biomater 69, 113, 2004.
42. Lawrence, J.P., Waked, W., Gillon, T.J., White, A.P., Spock, C.R., Biswas, D., Rosenberger, P., Troiano, N., Albert, T.J., Grauer, J.N. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit pos-terolateral fusion model. Spine 32, 1206, 2007.
43. Barnes, B., Boden, S.D., Louis-Ugbo, J., Tomak, P.R., Park, J.S., Park, M.S., Minamide, A. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine 30, 1127, 2005.
44. Welch, R.D., Jones, A.L., Bucholz, R.W., Reinert, C.M., Tjia, J.S., Pierce, W.A., Wozney, J.M., Li, X.J. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13, 1483, 1998.
45. Zerwekh, J.E., Kourosh, S., Scheinberg, R., Kitano, T., Edwards, M.L., Shin, D., Selby, D.K. Fibrillar collagen-biphasic calcium phosphate composite as a bone graft substitute for spinal fusion. J Orthop Res 10, 562, 1992.
46. Minamide, A., Tamaki, T., Kawakami, M., Hashizume, H., Yoshida, M., Sakata, R. Experimental spinal fusion using sintered bovine bone coated with type I collagen and re-combinant human bone morphogenetic protein-2. Spine 24, 1863, 1999.
47. Chistolini, P., Ruspantini, I., Bianco, P., Corsi, A., Cancedda, R., Quarto, R. Biomechanical evaluation of cell-loaded and cell-free hydroxyapatite implants for the reconstruction of segmental bone defects. J Mater Sci Mater Med 10, 739, 1999.
48. Ohyama, T., Kubo, Y., Iwata, H., Taki, W. Beta-tricalcium phosphate combined with recombinant human bone mor-phogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine. Neurol Med Chir (Tokyo) 44, 234, 2004.
49. Orii, H., Sotome, S., Chen, J., Wang, J., Shinomiya, K. Beta-tricalcium phosphate (beta-TCP) graft combined with bone marrow stromal cells (MSCs) for posterolateral spine fusion. J Med Dent Sci 52, 51, 2005.
50. Saito, N., Okada, T., Horiuchi, H., Ota, H., Takahashi, J., Murakami, N., Nawata, M., Kojima, S., Nozaki, K., Takaoka, K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 32, 381, 2003.
51. Karageorgiou, V., Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474, 2005.
52. Streuli, C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11, 634, 1999.
53. Jikko, A., Harris, S.E., Chen, D., Mendrick, D.L., Damsky, C.H. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res 14, 1075, 1999.
54. Yang, X.B., Bhatnagar, R.S., Li, S., Oreffo, R.O. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 10, 1148, 2004.
55. Hernigou, P., Beaujean, F. [Pseudarthrosis treated by percutaneous autologous bone marrow graft]. Rev Chir Orthop Reparatrice Appar Mot 83, 495, 1997.
56. Gangji, V., Hauzeur, J.P., Matos, C., De Maertelaer, V., Toungouz, M., Lambermont, M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A, 1153, 2004.
57. Connolly, J., Guse, R., Lippiello, L., Dehne, R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg Am 71, 684, 1989.
58. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshi-moto, K., Akashi, H., Shimada, K., Iwasaka, T., Imaizumi, T.; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427, 2002.
59. Healey, J.H., Zimmerman, P.A., McDonnell, J.M., Lane, J.M. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 280, 1990.
60. Garg, N.K., Gaur, S., Sharma, S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 64, 671, 1993.
61. Inoue, K., Ohgushi, H., Yoshikawa, T., Okumura, M., Sem-puku, T., Tamai, S., Dohi, Y. The effect of aging on bone formation in porous hydroxyapatite: biochemical and his-tological analysis. J Bone Miner Res 12, 989, 1997.
62. Kahn, A., Gibbons, R., Perkins, S., Gazit, D. Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthop Relat Res 69, 1995.
63. Haynesworth, S.E., Goshima, J., Goldberg, V.M., Caplan, A.I. Characterization of cells with osteogenic potential from human marrow. Bone 13, 81, 1992.
64. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
65. Bruder, S.P., Kraus, K.H., Goldberg, V.M., Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
66. D'Amour, K., Gage, F.H. New tools for human developmental biology. Nat Biotechnol 18, 381, 2000.
67. Martin, M.J., Muotri, A., Gage, F., Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11, 228, 2005.
68. McLain, R.F., Yerby, S.A., Moseley, T.A. Comparative morphometry of L4 vertebrae: comparison of large animal models for the human lumbar spine. Spine 27, E200, 2002.
69. Easley, N.E., Wang, M., McGrady, L.M., Toth, J.M. Bio-mechanical and radiographic evaluation of an ovine model for the human lumbar spine. Proc Inst Mech Eng [H] 222, 915, 2008.
70. Wilke, H.J., Kettler, A., Claes, L.E. Are sheep spines a valid biomechanical model for human spines? Spine 22, 2365, 1997.
71. Drespe, I.H., Polzhofer, G.K., Turner, A.S., Grauer, J.N. Animal models for spinal fusion. Spine J 5, 209 S, 2005.
72. Schumann, D., Ekaputra, A.K., Lam, C.X., Hutmacher, D.W. Biomaterials/scaffolds. Design of bioactive, multiphasic PCL/collagen type I and type II-PCL-TCP/collagen composite scaffolds for functional tissue engineering of os-teochondral repair tissue by using electrospinning and FDM techniques. Methods Mol Med 140, 101, 2007